Els Van Nieuwenhuysen
Cancer Institute (WIA)(IN)
Publications by Year
Research Areas
Ovarian cancer diagnosis and treatment, PARP inhibition in cancer therapy, Cancer Genomics and Diagnostics, Endometrial and Cervical Cancer Treatments, Cancer Immunotherapy and Biomarkers
Most-Cited Works
- → Durvalumab Plus Carboplatin/Paclitaxel Followed by Maintenance Durvalumab With or Without Olaparib as First-Line Treatment for Advanced Endometrial Cancer: The Phase III DUO-E Trial(2023)282 cited
- → High-grade serous tubo-ovarian cancer refined with single-cell RNA sequencing: specific cell subtypes influence survival and determine molecular subtype classification(2021)186 cited
- → Developing Organoids from Ovarian Cancer as Experimental and Preclinical Models(2020)184 cited
- → Obesity and survival among women with ovarian cancer: results from the Ovarian Cancer Association Consortium(2015)155 cited
- → Association of vitamin D levels and risk of ovarian cancer: a Mendelian randomization study(2016)145 cited
- → Lavage of the Uterine Cavity for Molecular Detection of Müllerian Duct Carcinomas: A Proof-of-Concept Study(2015)112 cited
- → Chromosomal Instability in Cell-Free DNA as a Highly Specific Biomarker for Detection of Ovarian Cancer in Women with Adnexal Masses(2016)108 cited
- → Adult body mass index and risk of ovarian cancer by subtype: a Mendelian randomization study(2016)93 cited
- → Shared genetics underlying epidemiological association between endometriosis and ovarian cancer(2015)79 cited
- → Tumor Treating Fields in combination with paclitaxel in recurrent ovarian carcinoma: Results of the INNOVATE pilot study(2018)76 cited